论文部分内容阅读
目的分析平阳霉素对口腔颌面部血管瘤的临床治疗效果。方法将我院2013-05-2014-09收治的68例口腔颌面部血管瘤患者,根据其入院的先后顺序分为观察组和对照组各34例,两组患者治疗药物为平阳霉素以及鱼肝油酸钠,比较其临床疗效。结果观察组有效率为94.12%,优于对照组79.22%,差异有统计学意义,P<0.05。观察组患者的不良反应发生率显著降低,差异有统计学意义,P<0.05。结论口腔颌面部血管瘤患者在临床治疗中应选择平阳霉素,此药物具有一定的安全可靠性,治疗时间较短。
Objective To analyze the clinical effect of pingyangmycin on oral and maxillofacial hemangiomas. Methods 68 patients with oral and maxillofacial hemangiomas admitted to our hospital from May 2013 to May 2014 were divided into observation group (34 cases) and control group (34 cases) according to the order of their admission. The two groups were treated with pingyangmycin Sodium codlate, its clinical efficacy. Results The observation group was 94.12%, better than the control group 79.22%, the difference was statistically significant, P <0.05. The incidence of adverse reactions in the observation group was significantly lower, the difference was statistically significant, P <0.05. Conclusion Patients with oral and maxillofacial hemangioma should choose pingyangmycin in clinical treatment. The drug has certain safety and reliability, and the treatment time is short.